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ABSTRACr Gene expression of Epstein-Barr virus (EBV)
was studied after microinjection of viral DNA into different
types of cells. Raji TK- cells, known to express viral gene
functions after superinfection with the EBV-P3HR-1 virus strain,
were attached to plastic dishes by using anti-lymphocyte IgG,
phytohemagglutinin, or concanavalin A as a ligand. It was dif-
ficult to inject DNA into the small and fragile Raji cells. After
formation of polykaryons by cell fusion, microinjection became
more efficient. At 24 hr after injection of P3HR-1 virus DNA,
90-100% of the injected cells expressed the early antigen
complex as observed by immunofluorescence staining 70-80%
of the cells simultaneously incorporated [3H]thymidine, indi-
cating that thymidine kinase is expressed after injection of viral
DNA. Additionally, synthesis of the virus capsid antigen was
demonstrated in 20-30% of the recipient Raji cells. Human
diploid fibroblasts, African green monkey kidney cells, and rat
fibroblasts, which do not represent natural target cells for EBV,
could also be induced to synthesis of early antigen complex by
injection of P3HR-1 virus DNA.
Epstein-Barr virus (EBV) has been found regularly associated
with two human malignancies, Burkitt's lymphoma and naso-
pharyngeal carcinoma (for review, see refs. 1 and 2). The virus
transforms human lymphocytes into permanently growing
lymphoblasts (3-6) and induces a malignant lymphoprolifer-
ative disease upon inoculation into New World primates (7-10).
It is of particular interest to study the transforming capacity of
EBV because of a possible causative role of the virus in the
development of malignancies in man.
One approach to the study of the EBV genome has been
comparison of the DNA of viral strains with different biological
properties (11-13). The majority of EBV isolates, regardless of
whether derived from patients with infectious mononucleosis,
Burkitt's lymphoma, or other diseases, are transforming viruses
and do not induce the early antigen complex (EA) upon su-
perinfection of Raji cells (a nonproducer cell line of Burkitt
origin). In contrast, the strain P3HR-1 (originating from a
Burkitt tumor) is a nontransforming virus with the unique ca-
pacity to induce the EA in Raji cells (14, 15).
Descriptive comparative studies have been published which
identified sequences deleted from or inserted into different viral
strains by partial denaturation mapping (16) and by analysis
of the restriction enzyme cleavage patterns (17, 18). Although
substantial progress has been made in the physical character-
ization of the EBV genome by Given and Kieff (18), attempts
to map biological functions on the genome have not been re-
ported. Considerable effort was made in different laboratories
to adapt transfection techniques that appeared to be useful in
the study of other herpes viruses (19-21) to EBV; however, so
far they have been without success.
Here we report that biological functions of EBV can be
studied by microinjection of EBV DNA into different types of
cells. Raji cells were selected for microinjection of EBV DNA
because they can be abortively infected with P3HR-1 virus,
resulting even in virus particle production. In addition, viral
gene expression was studied after injection of P3HR-1 virus
DNA into human and rat fibroblasts and into African green
monkey kidney cells, which are not naturally susceptible to viral
infection.
MATERIALS AND METHODS
Cells and Virus. Human embryonic fibroblasts (strain WI-38
and our own isolates), secondary green monkey kidney cells (TC
7 and our own isolates), and rat fibroblasts (rat 1) were grown
on glass slides in a minimal essential medium supplemented
with 10% fetal calf serum. P3HR-1 cells were obtained from
W. Henle; Raji TK- cells were from M. Nonoyama. These cells
were grown in RPMI-1640 (GIBCO) with 10% fetal calf serum.
Spontaneous reversion of Raji TK- cells to the TK+ phenotype
was not observed, even though the cells were kept in nonse-
lective medium for many months.
EBV was purified from P3HR-1 cells. Virus was induced by
addition of 12-O-tetradecanoylphorbol-13-acetate (20 ng/ml;
Sigma) 1 day after the cells were split (22). Virus was purified
from cells and supernatants as described (23), starting from 1.2
liters of culture fluid, except that dextran T-10 (Pharmacia) was
used for gradient centrifugation instead of sucrose (24). The
visible virus bands were collected, and the virus was pelleted
at 20,000 rpm for 1 hr at 40C in a SW 27 rotor (Beckman),
resuspended in virus suspension buffer (VSB; 0.01 M Tris-
HCI/0.01 M KCI/0.005 M EDTA, pH 7.4), and stored at
-70'C. One of five virus preparations was labeled with [3H]-
thymidine (1 ACi/ml; 1 Ci = 3.7 X 1010 becquerels) 1 day after
addition of the phorbol.
Purification of P3HR-1 Virus DNA. Virus isolated from a
total of 12 liters of P3HR-1 cell cultures was lysed with 1%
sarcosyl/0.025 M Tris-HCI/0.01 M EDTA, pH 8.5, and incu-
bated with proteinase K (100 ,ug/ml; Merck) at 370C for 2 hr.
Then, 0.01 M Tris-HCI/1 mM EDTA, pH 7.5, and solid CsCl
were added to a final volume of 10 ml and a final density of
1.705 g/ml. The lysate was centrifuged for 72 hr at 30,000 rpm
in a 50 Ti anglehead rotor (Beckman) at 20'C. Fractions (four
drops) were collected from the bottom of the tube through a
syringe needle (1.25-mm inner diameter) at a restricted flow
rate. Aliquots (3 Ml) were assayed for radioactivity, and the
DNA concentration was determined in the fractions neigh-
boring the peak fraction by measuring the optical density at 260
nm. The DNA concentration in the peak fraction estimated
from the specific activity was 140 Ag/ml. A portion (100 Ml) of
the peak fraction was loaded onto a Sephadex G-50 column (5.0
Abbreviations: EBV, Epstein-Barr virus; EA, early antigen complex;
VCA, virus capsid antigen.
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X 0.35 cm) and eluted with 0.01 M Tris-HCI/1 mM EDTA, pH
7.5, in 25-,Ml fractions. The two peak fractions of the Sephadex
column with DNA concentrations of 100 ,g/ml were used for
microinjection experiments.
Attachment of Raji Cells to Plastic Petri Dishes. Plastic
60-mm petri dishes containing 2.5 ml of 2.5% glutaraldehyde
were incubated for 2 hr at room temperature. The plates were
washed four times with sterile water and covered with 200,gl
of anti-lymphocyte IgG (1.3 mg/ml) (kindly provided by H.
Rodt). Alternatively, other ligands known to bind to cell sur-
faces, such as phytohemagglutinin P (Serva), concanavalin A
(Serva), pokeweed mitogen (Serva), and poly(l-lysine) (Sigma)
were used in a concentration of 100 gg/ml for coating the
plates. After incubation for 1-2 hr at 370C in a humidified at-
mosphere, the fluid was once more homogeneously distributed
on the surface of the plates and allowed to dry. After drying,
the plates were washed twice with phosphate-buffered saline
without Mg2+ and Ca2+ and filled with 3 ml of RPMI-1640
medium without serum. Raji cells were washed four times in
serum-free RPMI-1640 medium. About 107 cells were seeded
per 60-mm plate and were allowed to settle for 2-3 hr at 370C
in an atmosphere of 5% CO2 in air.
Fusion of Raji Cells. Cell fusion was induced by polyeth-
ylene glycol 1000 (Sigma) as described by Norwood et al. (25).
Plates with attached Raji cells were washed three times with
phosphate-buffered saline (free of Mg2+ and Ca2+) in order to
remove loosely bound cells. The saline was aspirated and 1.5-2.5
ml of 45-47% (wt/wt) polyethylene glycol in serum-free
RPMI-1640 medium, preincubated at 370C, was added to the
cell layer. The glycol solution was left on the cells for 60-70 sec;
then it was removed by three successive washes with phos-
phate-buffered saline. The cells were incubated in serum-free
RPMI-1640 medium at 37°C in a humidified CO2 incubator.
Cell fusion started immediately after polyethylene glycol
treatment and proceeded for several hours.
Immunofluorescence Staining. Fluorescence staining for
EPV EA and virus capsid antigen (VCA) was by standard pro-
cedures using indirect immunofluoreseence techniques (14, 26).
Microinjection. Microinjection has been described in detail
(27).
Autoradiography. Kodak nuclear track emulsion (NTB) was
used at a dilution of 1:10 (in H20). After exposure for 3 days
at 4°C, autoradiograms were developed with Kodak D-19 de-
veloper for 10 min at room temperature. After washing for 5
min in distilled water, autoradiograms were fixed with Kodak
Unifix for 5 min, washed again for 10 min in distilled water,
and air dried.
RESULTS
Expression of EBV DNA in Raji Cells After Microinjec-
tion. Large cells firmly adherent to a solid support are well
suited for microinjection experiments. The lymphoid Raji cells,
however, grow in suspension and are significantly smaller than
most mononuclear cells (e.g., human fibroblasts). Raji cells can
be attached efficiently to the surface of coated plastic dishes
(Fig. lb). Coating the dishes with anti-lymphocyte IgG, phy-
tohemagglutinin, or concanavalin A as ligands gave results
about equally good. In the case of concanavalin A, serum-
containing medium could be used. Plates coated with pokeweed
mitogen or poly(l-lysine) had less binding capacity or appeared
I': I
FIG. 1. (a) Suspension culture of Raji cells. (b) Adherent and spread Raji cells, 5 hr after plating onto an anti-lymphocyte IgG-coated plastic
dish; uncoated regions are free of cells. (c) Fused Raji cells, 10 hr after addition of polyethylene glycol. (d) Phase-contrast picture of fused cells.
(X 120.)
Proc. Natl. Acad. Sci. USA 77 (1980)
Proc. Natl. Acad. Sci. USA 77 (1980) 435
to be more toxic to the cells. Pretreatment of the cells with
glutaraldehyde prior coating was not essential but seemed to
give somewhat better reproducible attachment.
Single mononucleated Raji cells tolerated injection of only
about 5 X 10-12 ml. This volume could be increased about
10-fold when polyethylene glycol-fused Raji cells containing
5-10 nuclei were used as recipient cells for microinjection (Fig.
1 c and d). No spontaneous EBV antigen synthesis was observed
in cells made adherent and fused.
After injection of EBV DNA (100 ig/ml) into fused Raji cells,
the following virus induced functions were tested: (i) synthesis
of EA' (ii) expression of thymidine kinase; and (iii) synthesis
of VCA. EA and VCA were detected by indirect immunoflu-
orescence; thymidine kinase was studied by uptake of 3H-la-
beled thymidine into Raji TK- cells. To study EA and thymi-
dine kinase expression, microinjected cells were incubated for
24 hr in serum-free medium with [3H]thymidine (0.1 ACi/ml),
fixed with methanol, stained for EA, and subjected to autora-
diography. Of the injected cells, 90-100% stained for EA and
70-80% of these incorporated [3H]thymidine (Fig. 2 a and b).
Grains were observed over EA-positive cells but not over
mock-injected or uninjected cells. Also autoradiography of cells
immediately after DNA injection did not reveal any grains.
In order to test, whether thymidine incorporation was a
consequence of EA induction, EA synthesis was induced in Raji
TK- cells by the diterpene ester 12-O-tetradecanoylphorbol-
13-acetate TPA. About 10% of the Raji cells expressed EA after
4 days but did not reveal any [3H]thymidine uptake.
VCA expression was studied 48 hr after injection of viral
DNA into Raji cells; 20-30% of the recipient cells stained for
VCA. The VCA-positive cells were always found to incorporate
[3H]thymidine (Fig. 2 c and d).
The induction of EA and thymidine kinase was specific for
intact viral DNA; EcoRI digestion of the DNA abolished both
effects.
_P
FIG. 3. EA-positive rat fibroblasts, fixed and stained 48 hr after
injection of EBV DNA. (X450.)
The presence of a vast majority of uninjected cells sur-
rounding a defined number of injected cells within a defined
area of the plate served as an internal control for antigen ex-
pression and thymidine kinase activity.-
Expression of EBV DNA in Human Fibroblasts, Monkey
Kidney Cells, and Rat Fibroblasts. Expression of EA and VCA
was also studied in human fibroblasts, secondary African green
monkey kidney cells, and rat fibroblasts after microinjection
of EBV DNA. These cells do not represent natural target cells
for EBV and cannot be infected by the virus.
At 48 hr after injection, about one-fourth human fibroblasts,
monkey kidney cells, and rat fibroblasts revealed EA staining
(Fig. 3). Fig. 4 shows the time course of EA appearance in
WI-38 cells injected with viral DNA. EA-positive cells were first
observed at 48 hr after injection. At this time, 25-30% of the
cells exhibited EA fluorescence. With prolonged incubation the
number of EA-positive cells decreased slightly. After 8 days,
15% of the injected cells were still EA positive. No VCA syn-
thesis could be observed in cells studied 48, 72, or 96 hr after
injection of viral DNA.










FIG. 2. Expression of viral antigens and thymidine kinase in Raji
TK- cells injected with EBV DNA. (a) EA-positive multinucleated
Raji cell, 24 hr after injection. (b) Autoradiogram of section in a. (c)
VCA-positive mononucleated Raji cell, fixed and stained 48 hr after




FIG. 4. Time course ofEA synthesis in human fibroblasts. Each
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DISCUSSION
Microinjection allows the transfer of about 10-11 ml into each
mononucleated tissue culture cell (27). For a DNA with a mo-
lecular weight of 100 X 106 the DNA concentration has to be
at least 17 ;g/ml in order to transfer statistically one viral ge-
nome per injected cell. Obviously, higher DNA concentrations
should be used to obtain an efficient transfer of intact DNA into
the cells, because some of the DNA might be sheared during
the injection step. Induction of EBV synthesis in carrier cell lines
by diterpene esters increases the yield of virus DNA consider-
ably (22, 28). This enabled us to prepare viral DNA in a con-
centration of 100 jig/ml from CsCl density gradients without
any other concentration procedure, which may lead to frag-
mentation of the high molecular weight DNA. Freezing of the
DNA, required for lyophilization, destroys at least part of the
biological activity of EBV DNA and was therefore avoided.
(P3HR-1 virus DNA at a concentration of 25 ,ug/ml, which was
used in the initial experiments, lost its EA-inducing activity after
two cycles of freezing and thawing.)
It was not possible to use the small and not adherent lymphoid
Raji cells directly for microinjection. But we were able to anchor
these cells by using plates coated with anti-lymphocyte IgG,
phytohemagglutinin, or concanavalin A, and the problem of
the small cell size of the lymphoblasts was solved by cell fusion
of the attached cells to polykaryons.
Because Raji cells were attached to plastic petri dishes, ace-
tone could not be used for fixation, and the cells had to be fixed
with methanol, which inactivates the R component of the EA
(29). Thus, only the expression of the EA D component could
be studied.
We have shown that P3HR-1 virus DNA is capable of in-
ducing EA, VCA, and thymidine kinase after injection of viral
DNA into Raji cells. From these experiments, however, no
conclusion can be drawn as to whether the genes expressed after
viral DNA injection are encoded by the input viral DNA or by
endogenous EBV genomes. It even cannot be excluded that
thymidine kinase expression is due to the activation of a pre-
viously silent cellular gene. It was our main objective to dem-
onstrate that injected viral DNA shows the same biological
activity as the infecting P3HR-1 virus.
The high rate of conversion of Raji cells to EA expression after
injection of P3HR-1 virus DNA indicates that the injection
process is highly efficient. This is not surprising if one considers
that, in plaque-purified simian virus 40 preparations, about 100
particles are required to yield 1 plaque-forming unit in tissue
culture infection, whereas 1 virus particle is infectious upon
injection into the cell (30).
EA can also be induced in virus-nonsusceptible human fi-
broblasts, African green monkey kidney cells, and rat fibroblasts
after injection of P3HR-1 virus DNA. This demonstrates that
the natural barrier against an EBV infection of these cells must
be located in one of the early events-adsorption, penetration,
or uncoating. Virus adsorption studies indicate that these cells
do not possess receptors for EBV (unpublished observation). A
similar mode of host range restriction, which could be by-passed
by injection of virus particles or viral DNA, has been demon-
strated for simian virus 40 and polyoma viruses (for review, see
ref. 30). The fact that human fibroblasts, monkey kidney cells,
and rat fibroblasts did not synthesize viral capsid proteins may
point to an additional regulation mechanism for the expression
of late viral genes in these cells.
Until now, no EBV nuclear antigen expression could be de-
tected after injection of viral DNA into human and rat fibro-
blasts. The reason for this may be technical and requires further
investigation.
The expression of EBV genes after microinjection of viral
DNA obviously provides an approach to mapping biological
functions on the viral genome. We have been able toinduce EA
by injection of DNA fragments, which will be reported in detail
elsewhere. It will be of special interest to study the transforming
potential of EBV DNA and of EBV DNA fragments and to
learn if transformation can be initiated by injection of viral
DNA into human fibroblasts.
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